Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab′)2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival

Tom Bäck; Nicolas Chouin; Sture Lindegren; Helena Kahu; Holger Jensen; Per Albertsson; Stig Palm

doi:10.2967/jnumed.116.178327

Research ArticleTheranostics

Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with ²¹¹At-MX35-F(ab′)₂: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival

Tom Bäck, Nicolas Chouin, Sture Lindegren, Helena Kahu, Holger Jensen, Per Albertsson and Stig Palm

Journal of Nuclear Medicine April 2017, 58 (4) 598-604; DOI: https://doi.org/10.2967/jnumed.116.178327

Tom Bäck

1Department of Radiation Physics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Nicolas Chouin

2LUNAM Université, Oniris, AMaROC, Nantes, France

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sture Lindegren

1Department of Radiation Physics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helena Kahu

3Department of Oncology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Holger Jensen

4PET and Cyclotron Unit, Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Copenhagen, Denmark

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Per Albertsson

3Department of Oncology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; and

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Stig Palm

1Department of Radiation Physics, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 58, Issue 4

April 1, 2017

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with 211At-MX35-F(ab′)2: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with ²¹¹At-MX35-F(ab′)₂: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival

Tom Bäck, Nicolas Chouin, Sture Lindegren, Helena Kahu, Holger Jensen, Per Albertsson, Stig Palm

Journal of Nuclear Medicine Apr 2017, 58 (4) 598-604; DOI: 10.2967/jnumed.116.178327

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with ²¹¹At-MX35-F(ab′)₂: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival

Tom Bäck, Nicolas Chouin, Sture Lindegren, Helena Kahu, Holger Jensen, Per Albertsson, Stig Palm

Journal of Nuclear Medicine Apr 2017, 58 (4) 598-604; DOI: 10.2967/jnumed.116.178327

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy
Radiolabeled Antibodies Against Mullerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer
Model of Intraperitoneal Targeted {alpha}-Particle Therapy Shows That Posttherapy Cold-Antibody Boost Enhances Microtumor Radiation Dose and Treatable Tumor Sizes

Google Scholar

Theranostics

¹⁷⁷Lu-Labeled Anticlaudin 6 Monoclonal Antibody for Targeted Therapy in Esophageal Cancer
Terbium-161, a Promising New Theranostic Radionuclide
Association of change in PSMA avid tumor burden during 177Lu-PSMA-617 therapy with overall survival: Should mid-point PET become standard protocol?

Show more Theranostics

Basic

Dopamine D₁ Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
Optical Navigation of the Drop-In γ-Probe as a Means to Strengthen the Connection Between Robot-Assisted and Radioguided Surgery
Synthesis and Preclinical Evaluation of a ⁶⁸Ga-Labeled Adnectin, ⁶⁸Ga-BMS-986192, as a PET Agent for Imaging PD-L1 Expression

Show more Basic

Keywords

targeted alpha therapy
radioimmunotherapy
alpha-particles
211At
dosimetry

Main menu

User menu

Search

Cure of Human Ovarian Carcinoma Solid Xenografts by Fractionated α-Radioimmunotherapy with ²¹¹At-MX35-F(ab′)₂: Influence of Absorbed Tumor Dose and Effect on Long-Term Survival

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Theranostics

Basic

Similar Articles

Keywords